ArticleNPJ breast cancer2025
DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer.
Abstract read
In one paragraph
Article in NPJ breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors.
Elizabeth M ChislockSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Tien-Chi PanSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Dhruv PantSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Yan ChenSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
George WoodfieldSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Jewell GravesSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Matthew R Lawrence-PaulSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
George K BelkaSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Jianping WangSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Lauren BayneSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Tatiana BlanchardSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Meaghan SmithSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Xiaodan JiSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Natalie N C ShihDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Danielle Soucier-ErnstSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Noah GoodmanSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Isoris NivarSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Brooke GoodspeedSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Shannon DeLucaSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
John NdicuSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Candace ClarkSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Melissa LangerSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
S William StavropoulosSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
William DeMuthDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Andrew MorschauserDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
William MurphyDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Anupma NayakSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Michael FeldmanSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Amy ClarkSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.
Liping YuBD Biosciences, San Jose, CA, USA.
Kevin JudgeBD Biosciences, San Jose, CA, USA.
Scott BornheimerBD Biosciences, San Jose, CA, USA.
Charles H PletcherDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Jonni S MooreDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Angela DeMicheleSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA. angela.demichele@pennmedicine.upenn.edu.
Lewis A ChodoshSecondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA. chodosh@pennmedicine.upenn.edu.
Funding
UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3MSecondary Prevention through Surveillance and InterventionR01CA208273 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHODOSH, LEWIS A, DEMICHELE, ANGELA · 2017 to 2021
$3.2MNCI NIH HHS P30 CA016520NCI NIH HHS R01 CA208273NIH HHS CA208273Susan G. Komen PDF17483333
Abstract
The presence of bone marrow (BM) disseminated tumor cells (DTC
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.